Morrison Foerster is recommended for experience in advising both multinational clients and PRC state owned enterprises in the healthcare and life sciences space. The firm has a strong record in advising on collaboration and licensing agreements for the commercial sale of medical drugs, as well as investment funds work for start-ups and private equity funds in the area of biomedicine. The team is led by Chuan Sun, who is located in Shanghai and offers expertise in both transactional work and legal advice pertaining to clinical trials, alongside the Hong Kong based duo of Thomas Chou and Gordon Milner. B. Chen Zhu and associate Sarah Wang are also key. Ruomu Li left the firm, joining Cooley LLP in December 2022.
Testimonials
Collated independently by Legal 500 research team.
‘With significant and long-term industry experience in the field of life sciences and healthcare, as well as outstanding achievements in overseas private equity financing, the team is stable and provides continuous legal support to clients.’
‘Chuan Sun is a veteran in the industry and is personally on the front line to provide continuous and efficient legal services to clients.'
Key clients
- Ally Bridge Group
- CBC Group
- Jamieson Laboratories Ltd
- Hangzhou DAC Biotechnology Co., Ltd.
- Celadon Partners
- Jiangsu Hengrui Medicine Co., Ltd.
- Chugai Pharmaceutical
- Triastek
Work highlights
- Advised Hangzhou DAC Biotechnology Co., Ltd. (“DAC Biotechnology”) on its collaboration and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (“Janssen”) for the development and commercialization of antibody drug conjugate (ADC) products.
- Represented Ally Bridge Group in various growth, late stage and public life sciences investments across the US and Europe worth approximately US$700 million, including the US$101 million Series B financing of Endeavor BioMedicines and the US$200 million Series C investment of Transcarent.
- Advised Jamieson Laboratories and its parent company Jamieson Wellness Inc. on their partnership with leading international private equity firm DCP Capital, which included DCP’s purchase of a minority interest in Jamieson’s Chinese operations.
Lawyers
Practice head
The lawyer(s) leading their teams.
Chuan Sun, Thomas Chou, Gordon Milner